{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:05:17Z","timestamp":1792670717967,"version":"4.5.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens Disease"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1111\/2049-632x.12015","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T21:32:51Z","timestamp":1355434371000},"page":"39-45","source":"Crossref","is-referenced-by-count":43,"title":["Eradication of<i>Pseudomonas aeruginosa<\/i>biofilms on cultured airway cells by a fosfomycin\/tobramycin antibiotic combination"],"prefix":"10.1093","volume":"67","author":[{"given":"Gregory G.","family":"Anderson","sequence":"first","affiliation":[{"name":"Department of Biology; Indiana University Purdue University Indianapolis; Indianapolis; IN; USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Kenney","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc.; Seattle; WA; USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"MacLeod","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc.; Seattle; WA; USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noreen R.","family":"Henig","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc.; Foster City; CA; USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"O'Toole","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology; Geisel School of Medicine at Dartmouth; Hanover; NH; USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,1,10]]},"reference":[{"issue":"Suppl 1","key":"10.1111\/2049-632X.12015-BIB0001|fim12015-cit-0001","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000222026","article-title":"In vitro sensitivity of anaerobic bacteria to fosfomycin","volume":"23","author":"Altes Gutierrez","year":"1977","journal-title":"Chemotherapy"},{"key":"10.1111\/2049-632X.12015-BIB0002|fim12015-cit-0002","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1128\/IAI.01373-07","article-title":"In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells","volume":"76","author":"Anderson","year":"2008","journal-title":"Infect Immun"},{"key":"10.1111\/2049-632X.12015-BIB0003|fim12015-cit-0003","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1128\/IAI.00865-09","article-title":"The Pseudomonas aeruginosa magnesium transporter MgtE inhibits transcription of the type III secretion system","volume":"78","author":"Anderson","year":"2010","journal-title":"Infect Immun"},{"key":"10.1111\/2049-632X.12015-BIB0004|fim12015-cit-0004","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/AAC.48.7.2659-2664.2004","article-title":"Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms","volume":"48","author":"Borriello","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/2049-632X.12015-BIB0005|fim12015-cit-0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1183\/09031936.03.00057003","article-title":"New concepts of the pathogenesis of cystic fibrosis lung disease","volume":"23","author":"Boucher","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1111\/2049-632X.12015-BIB0006|fim12015-cit-0006","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.gt.3301741","article-title":"Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting","volume":"9","author":"Bruscia","year":"2002","journal-title":"Gene Ther"},{"key":"10.1111\/2049-632X.12015-BIB0007|fim12015-cit-0007","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1165\/ajrcmb.10.1.7507342","article-title":"CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells","volume":"10","author":"Cozens","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1111\/2049-632X.12015-BIB0008|fim12015-cit-0008","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1574-6976.2010.00237.x","article-title":"Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease","volume":"35","author":"Doring","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"10.1111\/2049-632X.12015-BIB0009|fim12015-cit-0009","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ppul.21198","article-title":"Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008","volume":"45","author":"Emerson","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/2049-632X.12015-BIB0010|fim12015-cit-0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1378\/chest.122.1.219","article-title":"Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis","volume":"122","author":"Geller","year":"2002","journal-title":"Chest"},{"key":"10.1111\/2049-632X.12015-BIB0011|fim12015-cit-0011","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/2049-632X.12015-BIB0012|fim12015-cit-0012","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.coph.2006.12.005","article-title":"Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis","volume":"7","author":"Gomez","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1111\/2049-632X.12015-BIB0013|fim12015-cit-0013","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.devcel.2004.08.020","article-title":"A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa","volume":"7","author":"Goodman","year":"2004","journal-title":"Dev Cell"},{"key":"10.1111\/2049-632X.12015-BIB0014|fim12015-cit-0014","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1183\/09031936.00146807","article-title":"Inhibition of airway proteases in cystic fibrosis lung disease","volume":"32","author":"Griese","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1111\/2049-632X.12015-BIB0015|fim12015-cit-0015","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/clinchem\/44.5.1129","article-title":"Laboratory guidelines for monitoring of antimicrobial drugs. National Academy of Clinical Biochemistry","volume":"44","author":"Hammett-S r","year":"1998","journal-title":"Clin Chem"},{"key":"10.1111\/2049-632X.12015-BIB0016|fim12015-cit-0016","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1128\/IAI.67.10.5530-5537.1999","article-title":"Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells","volume":"67","author":"Hauser","year":"1999","journal-title":"Infect Immun"},{"key":"10.1111\/2049-632X.12015-BIB0017|fim12015-cit-0017","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/24.5.657","article-title":"An increase in the antimicrobial activity in vitro of fosfomycin under anaerobic conditions","volume":"24","author":"Inouye","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/2049-632X.12015-BIB0018|fim12015-cit-0018","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/JB.187.4.1441-1454.2005","article-title":"A three-component regulatory system regulates biofilm maturation and type III secretion in Pseudomonas aeruginosa","volume":"187","author":"Kuchma","year":"2005","journal-title":"J Bacteriol"},{"key":"10.1111\/2049-632X.12015-BIB0019|fim12015-cit-0019","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2958.2004.04402.x","article-title":"A novel two-component system controls the expression of Pseudomonas aeruginosa fimbrial cup genes","volume":"55","author":"Kulasekara","year":"2005","journal-title":"Mol Microbiol"},{"key":"10.1111\/2049-632X.12015-BIB0020|fim12015-cit-0020","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1128\/AAC.39.5.1038","article-title":"Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm","volume":"39","author":"Kumon","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/2049-632X.12015-BIB0021|fim12015-cit-0021","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1365-2958.2004.04331.x","article-title":"A novel sensor kinase-response regulator hybrid regulates type III secretion and is required for virulence in Pseudomonas aeruginosa","volume":"54","author":"Laskowski","year":"2004","journal-title":"Mol Microbiol"},{"key":"10.1111\/2049-632X.12015-BIB0022|fim12015-cit-0022","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.coph.2008.01.010","article-title":"Macrolides as immunomodulatory medications for the therapy of chronic lung diseases","volume":"8","author":"Lopez-Boado","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1111\/2049-632X.12015-BIB0023|fim12015-cit-0023","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jac\/dkp282","article-title":"Antibacterial activities of a fosfomycin\/tobramycin combination: a novel inhaled antibiotic for bronchiectasis","volume":"64","author":"MacLeod","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/2049-632X.12015-BIB0024|fim12015-cit-0024","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/AAC.05958-11","article-title":"Fosfomycin enhances the active transport of tobramycin in Pseudomonas aeruginosa","volume":"56","author":"MacLeod","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/2049-632X.12015-BIB0025|fim12015-cit-0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0966-842X(00)01913-2","article-title":"Mechanisms of biofilm resistance to antimicrobial agents","volume":"9","author":"Mah","year":"2001","journal-title":"Trends Microbiol"},{"key":"10.1111\/2049-632X.12015-BIB0026|fim12015-cit-0026","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s10156-002-0186-6","article-title":"Role of fosfomycin in a synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm","volume":"8","author":"Monden","year":"2002","journal-title":"J Infect Chemother"},{"key":"10.1111\/2049-632X.12015-BIB0027|fim12015-cit-0027","doi-asserted-by":"crossref","first-page":"L25","DOI":"10.1152\/ajplung.00391.2007","article-title":"The {Delta}F508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability","volume":"295","author":"Moreau-Marquis","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1111\/2049-632X.12015-BIB0028|fim12015-cit-0028","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1165\/rcmb.2008-0299OC","article-title":"Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells","volume":"41","author":"Moreau-Marquis","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1111\/2049-632X.12015-BIB0029|fim12015-cit-0029","first-page":"e2186","article-title":"Co-culture models of Pseudomonas aeruginosa biofilms grown on live human airway cells","volume":"44","author":"Moreau-Marquis","year":"2010","journal-title":"J Vis Exp"},{"key":"10.1111\/2049-632X.12015-BIB0030|fim12015-cit-0030","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1164\/rccm.201009-1430OC","article-title":"Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections","volume":"183","author":"Mowat","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/2049-632X.12015-BIB0031|fim12015-cit-0031","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.blo.0000175714.68624.74","article-title":"Biofilms and antimicrobial resistance","volume":"437","author":"Patel","year":"2005","journal-title":"Clin Orthop Relat Res"},{"key":"10.1111\/2049-632X.12015-BIB0032|fim12015-cit-0032","first-page":"CD006682","article-title":"Duration of intravenous antibiotic therapy in people with cystic fibrosis","volume":"1","author":"Plummer","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/2049-632X.12015-BIB0033|fim12015-cit-0033","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jcf.2009.08.004","article-title":"Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: a review","volume":"8","author":"Ratjen","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1111\/2049-632X.12015-BIB0034|fim12015-cit-0034","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2958.2004.04194.x","article-title":"ExoU is a potent intracellular phospholipase","volume":"53","author":"Sato","year":"2004","journal-title":"Mol Microbiol"},{"key":"10.1111\/2049-632X.12015-BIB0035|fim12015-cit-0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00019048-200106000-00004","article-title":"Fosfomycin: a review","volume":"10","author":"Shrestha","year":"2001","journal-title":"Infect Dis Clin Pract"},{"key":"10.1111\/2049-632X.12015-BIB0036|fim12015-cit-0036","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1073\/pnas.0602138103","article-title":"Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients","volume":"103","author":"Smith","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/2049-632X.12015-BIB0037|fim12015-cit-0037","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/35023079","article-title":"Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen","volume":"406","author":"Stover","year":"2000","journal-title":"Nature"},{"key":"10.1111\/2049-632X.12015-BIB0038|fim12015-cit-0038","doi-asserted-by":"crossref","first-page":"36762","DOI":"10.1074\/jbc.M508944200","article-title":"The short apical membrane half-life of rescued {Delta}F508-cystic fibrosis transmembrane conductance regulator (CFTR) results from accelerated endocytosis of {Delta}F508-CFTR in polarized human airway epithelial cells","volume":"280","author":"Swiatecka-Urban","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1111\/2049-632X.12015-BIB0039|fim12015-cit-0039","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/AAC.47.1.317-323.2003","article-title":"Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin","volume":"47","author":"Walters","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/2049-632X.12015-BIB0040|fim12015-cit-0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2958.2006.05390.x","article-title":"Cell wall-inhibitory antibiotics activate the alginate biosynthesis operon in Pseudomonas aeruginosa: roles of sigma (AlgT) and the AlgW and Prc proteases","volume":"62","author":"Wood","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1111\/2049-632X.12015-BIB0041|fim12015-cit-0041","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/AEM.64.10.4035-4039.1998","article-title":"Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability","volume":"64","author":"Xu","year":"1998","journal-title":"Appl Environ Microbiol"},{"key":"10.1111\/2049-632X.12015-BIB0042|fim12015-cit-0042","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2958.2006.05412.x","article-title":"Transcriptional regulation of the Pseudomonas aeruginosa type III secretion system","volume":"62","author":"Yahr","year":"2006","journal-title":"Mol Microbiol"}],"container-title":["Pathogens and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/67\/1\/39\/17942541\/67-1-39.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T10:33:21Z","timestamp":1643884401000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1111\/2049-632X.12015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,10]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"URL":"https:\/\/doi.org\/10.1111\/2049-632x.12015","relation":{},"ISSN":["2049-632X"],"issn-type":[{"value":"2049-632X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,10]]}}}